Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?

Neurilemmomas are benign neoplasms presumedly derived from Schwann cells which rarely originate within the central nervous system. Moreover, their intraventricular location has been seldom noticed with less than 30 cases reported worldwide. Here, we add another case study to the record as well as th...

Full description

Saved in:
Bibliographic Details
Main Authors: Miguel Fdo. Salazar, Martha Lilia Tena Suck, Daniel Rembao Bojórquez, Citlaltepetl Salinas Lara
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Pathology
Online Access:http://dx.doi.org/10.1155/2016/2494175
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552851535036416
author Miguel Fdo. Salazar
Martha Lilia Tena Suck
Daniel Rembao Bojórquez
Citlaltepetl Salinas Lara
author_facet Miguel Fdo. Salazar
Martha Lilia Tena Suck
Daniel Rembao Bojórquez
Citlaltepetl Salinas Lara
author_sort Miguel Fdo. Salazar
collection DOAJ
description Neurilemmomas are benign neoplasms presumedly derived from Schwann cells which rarely originate within the central nervous system. Moreover, their intraventricular location has been seldom noticed with less than 30 cases reported worldwide. Here, we add another case study to the record as well as the fifth one in Latin American population. A 16-year-old boy without significant past clinical data debuted with headache and progressive left eye blindness during six months. Neuroimaging scans showed a bulky, multiloculated, intraventricular tumour emerging from the posterior horn of the left lateral ventricle. Microscopically, the lesion put on view the classical schwannian histology: spindle cells arranged in both compact and loosely textured areas. Verocay bodies were not present but vessel hyalinisation, pericellular reticulin, and senescent atypia were observed. The immunoperoxidase reactions were also consistent with neurilemmal differentiation; however, glial fibrillary acidic protein expression was widespread and unexpectedly seen. Traditionally conceived as “nerve sheath tumours” the dual immunophenotype herein demonstrated points to a different histogenetical pathway other than sheer Schwann cell derivation. As previously advised by some authors, neoplastic transformation from a multipotent stem cell may explain the occasional finding of these tumours in unconventional intracranial compartments.
format Article
id doaj-art-5d030e77add540adade4f9165caeaa93
institution Kabale University
issn 2090-6781
2090-679X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Pathology
spelling doaj-art-5d030e77add540adade4f9165caeaa932025-02-03T05:57:41ZengWileyCase Reports in Pathology2090-67812090-679X2016-01-01201610.1155/2016/24941752494175Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?Miguel Fdo. Salazar0Martha Lilia Tena Suck1Daniel Rembao Bojórquez2Citlaltepetl Salinas Lara3Pathology Unit, Neuropathology Service, Mexico General Hospital, Cuauhtémoc, 06726 Mexico City, DF, MexicoDepartment of Neuropathology, National Institute of Neurology & Neurosurgery “Manuel Velasco Suárez”, Tlalpan, 14269 Mexico City, DF, MexicoDepartment of Neuropathology, National Institute of Neurology & Neurosurgery “Manuel Velasco Suárez”, Tlalpan, 14269 Mexico City, DF, MexicoDepartment of Neuropathology, National Institute of Neurology & Neurosurgery “Manuel Velasco Suárez”, Tlalpan, 14269 Mexico City, DF, MexicoNeurilemmomas are benign neoplasms presumedly derived from Schwann cells which rarely originate within the central nervous system. Moreover, their intraventricular location has been seldom noticed with less than 30 cases reported worldwide. Here, we add another case study to the record as well as the fifth one in Latin American population. A 16-year-old boy without significant past clinical data debuted with headache and progressive left eye blindness during six months. Neuroimaging scans showed a bulky, multiloculated, intraventricular tumour emerging from the posterior horn of the left lateral ventricle. Microscopically, the lesion put on view the classical schwannian histology: spindle cells arranged in both compact and loosely textured areas. Verocay bodies were not present but vessel hyalinisation, pericellular reticulin, and senescent atypia were observed. The immunoperoxidase reactions were also consistent with neurilemmal differentiation; however, glial fibrillary acidic protein expression was widespread and unexpectedly seen. Traditionally conceived as “nerve sheath tumours” the dual immunophenotype herein demonstrated points to a different histogenetical pathway other than sheer Schwann cell derivation. As previously advised by some authors, neoplastic transformation from a multipotent stem cell may explain the occasional finding of these tumours in unconventional intracranial compartments.http://dx.doi.org/10.1155/2016/2494175
spellingShingle Miguel Fdo. Salazar
Martha Lilia Tena Suck
Daniel Rembao Bojórquez
Citlaltepetl Salinas Lara
Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
Case Reports in Pathology
title Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
title_full Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
title_fullStr Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
title_full_unstemmed Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
title_short Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?
title_sort intraventricular neurilemmoma schwannoma shall gfap immunostaining be regarded as a histogenetical tag or as a mere histomimetical trait
url http://dx.doi.org/10.1155/2016/2494175
work_keys_str_mv AT miguelfdosalazar intraventricularneurilemmomaschwannomashallgfapimmunostainingberegardedasahistogeneticaltagorasamerehistomimeticaltrait
AT marthaliliatenasuck intraventricularneurilemmomaschwannomashallgfapimmunostainingberegardedasahistogeneticaltagorasamerehistomimeticaltrait
AT danielrembaobojorquez intraventricularneurilemmomaschwannomashallgfapimmunostainingberegardedasahistogeneticaltagorasamerehistomimeticaltrait
AT citlaltepetlsalinaslara intraventricularneurilemmomaschwannomashallgfapimmunostainingberegardedasahistogeneticaltagorasamerehistomimeticaltrait